This detailed exploration of the role of eccDNA in mediating MDM2 amplification and its influence on tumor drug resistance underlines the complex relationship between eccDNA and key proteins in the p53 pathway, providing fresh insights for developing therapeutic strategies against cancer. This evidence concerns the gene TP53 and cancer.